ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new ...
ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Abbott has received emergency authorizations from the FDA for two of its Alinity m PCR assays: one that tests only for COVID-19 and another that can detect the coronavirus alongside respiratory ...
AMSTERDAM, April 23, 2018 /PRNewswire/ -- Sanquin and Abbott (NYSE: ABT) announced today that they signed a multiple-year contract for the supply of primary serological equipment and consumables, ...
ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer ...
Abbott announced the introduction of Alinity, its harmonized family of next-generation systems across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening and ...
Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
Abbott has become the latest company to team up with Alzheimer’s disease blood test developer ALZpath. | Abbott has become ...
ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results